🔴 Sellas Life Sciences is trading 4.43% down today after September inflation topped forecasts

Sellas Life Sciences is trading at $11.86, down 4.43%, as investors react to September CPI above forecasts.

• Headline inflation was 3.7% year over year, above the 3.6% forecast; core inflation was 2.6%, above the 2.5% forecast.
• The S&P 500 is down 1.40% and Nasdaq is down 2.17%, reflecting broad equity weakness.
• No new company-specific catalyst was identified; coverage focused on pending REGAL analysis and ownership disclosures.